Novartis CEO Vas Narasimhan defended the company's decision to delay telling the FDA about inaccurate data involving its $2.1 million gene therapy Zolgensma, saying that it "tried to do the right things" in the process, according to STAT.
Pharmacy
Apple and Eli Lilly have partnered on new research to determine whether health data from the iPhone and Apple Watch can detect early signs of dementia, according to CNBC.
Medicare has finalized its long overdue national coverage decision on CAR-T therapy, an innovative but expensive new cancer treatment that uses patients' immune cells to fight against the disease.
CVS Health released its second quarter earnings report Aug. 7, beating analyst predictions as its three businesses reported better-than-expected results, according to CNBC.
Seven of the 18 top-paid nonexecutive board chairs were in the pharmaceutical industry last year, according to data from intelligence provider MyLogIQ, cited by the Arizona Republic newspaper.
Advertisement
Port Townsend, Wash.-based Jefferson Healthcare has opened a retail pharmacy that will dispense specialty drugs, offer home-delivery prescriptions and stock over-the-counter drugs and medical supplies, according to the Port Townsend Leader.
PillPack, which was acquired by Amazon last year, is fighting with industry heavyweights CVS and Walgreens over patient prescription transfers, according to CNBC.
Walgreens plans to close 200 stores in the U.S., decreasing its real estate footprint by about 3 percent, according to CNBC.
The FDA said Novartis used data it knew was inaccurate in its application for its $2.1 million gene therapy Zolgensma, and the agency is threatening to take criminal action against the drugmaker.
Brand-name drugmakers are increasingly making generic versions of their own drugs, a strategy that keeps drug costs high and stifles competition, critics of the practice told Kaiser Health News.